DK0986753T4 - Fremgangsmåde til uddragning af kvantitativ information, hvad angår en påvirkning af et cellulært respons - Google Patents

Fremgangsmåde til uddragning af kvantitativ information, hvad angår en påvirkning af et cellulært respons

Info

Publication number
DK0986753T4
DK0986753T4 DK98913541T DK98913541T DK0986753T4 DK 0986753 T4 DK0986753 T4 DK 0986753T4 DK 98913541 T DK98913541 T DK 98913541T DK 98913541 T DK98913541 T DK 98913541T DK 0986753 T4 DK0986753 T4 DK 0986753T4
Authority
DK
Denmark
Prior art keywords
component
protein
influence
protein kinase
luminophore
Prior art date
Application number
DK98913541T
Other languages
Danish (da)
English (en)
Other versions
DK0986753T3 (da
Inventor
Sara Petersen Bjorn
Almholt Kasper
Ole Thastrup
Soren Tullin
Kurt Scudder
Bernard Robert Terry
Per Olof Gunnar Arkhammar
Original Assignee
Bioimage As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8092994&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0986753(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bioimage As filed Critical Bioimage As
Publication of DK0986753T3 publication Critical patent/DK0986753T3/da
Application granted granted Critical
Publication of DK0986753T4 publication Critical patent/DK0986753T4/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5035—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on sub-cellular localization
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/43504—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates
    • G01N2333/43595—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from coelenteratae, e.g. medusae
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205—Phosphotransferases in general
    • G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK98913541T 1997-04-07 1998-04-07 Fremgangsmåde til uddragning af kvantitativ information, hvad angår en påvirkning af et cellulært respons DK0986753T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK39297 1997-04-07
PCT/DK1998/000145 WO1998045704A2 (fr) 1997-04-07 1998-04-07 Procede permettant d'extraire des informations quantitatives ayant trait a une influence exercee sur une reponse cellulaire

Publications (2)

Publication Number Publication Date
DK0986753T3 DK0986753T3 (da) 2002-07-22
DK0986753T4 true DK0986753T4 (da) 2005-12-19

Family

ID=8092994

Family Applications (2)

Application Number Title Priority Date Filing Date
DK98913541T DK0986753T4 (da) 1997-04-07 1998-04-07 Fremgangsmåde til uddragning af kvantitativ information, hvad angår en påvirkning af et cellulært respons
DK03028919T DK1435519T3 (da) 1997-04-07 1998-04-07 Fremgangsmåde til screening af substanser for effekt på cAMP-niveauer baseret på intracellulær translokation af PKA

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK03028919T DK1435519T3 (da) 1997-04-07 1998-04-07 Fremgangsmåde til screening af substanser for effekt på cAMP-niveauer baseret på intracellulær translokation af PKA

Country Status (11)

Country Link
US (3) US6518021B1 (fr)
EP (3) EP0986753B2 (fr)
JP (1) JP2001522454A (fr)
AT (3) ATE354089T1 (fr)
AU (1) AU6820998A (fr)
CA (1) CA2286293C (fr)
DE (4) DE69804446T3 (fr)
DK (2) DK0986753T4 (fr)
ES (2) ES2191575T3 (fr)
PT (2) PT1199564E (fr)
WO (1) WO1998045704A2 (fr)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69712731T2 (de) 1996-01-26 2003-02-06 Virco Nv Verfahren zur überwachung der chemotherapie von hiv-positiven patienten basierend auf der phenotypischen medikamentempfindlichkeit vom hiv stamm des patienten
US7062219B2 (en) 1997-01-31 2006-06-13 Odyssey Thera Inc. Protein fragment complementation assays for high-throughput and high-content screening
US6759206B1 (en) 1997-02-27 2004-07-06 Cellomics, Inc. System for cell-based screening
US6416959B1 (en) 1997-02-27 2002-07-09 Kenneth Giuliano System for cell-based screening
US7853411B2 (en) 1997-02-27 2010-12-14 Cellomics, Inc. System for cell-based screening
DE69804446T3 (de) * 1997-04-07 2006-08-24 Bioimage A/S Verfahren um quantitativen informationen über einflüsse auf zelluläre reaktionen zu entnehmen
US7160687B1 (en) 1997-05-29 2007-01-09 Cellomics, Inc. Miniaturized cell array methods and apparatus for cell-based screening
US6235512B1 (en) * 1997-07-01 2001-05-22 Tularik Inc. IKK-α proteins, nucleic acids and methods
US20050221280A1 (en) 1998-02-02 2005-10-06 Odyssey Thera, Inc. Protein-protein interactions for pharmacological profiling
US20030036855A1 (en) 1998-03-16 2003-02-20 Praelux Incorporated, A Corporation Of New Jersey Method and apparatus for screening chemical compounds
US6388788B1 (en) 1998-03-16 2002-05-14 Praelux, Inc. Method and apparatus for screening chemical compounds
DE69938293T2 (de) * 1998-03-27 2009-03-12 Bruce J. Beverly Hills Bryan Luciferase, gfp fluoreszenzproteine, kodierende nukleinsaüre und ihre verwendung in der diagnose
US6037133A (en) * 1998-04-17 2000-03-14 Clontech Laboratories, Inc. IκBEGFP constructs, cell lines and methods of use
US6844315B2 (en) * 1998-05-20 2005-01-18 Erasmus Universiteit Rotterdam Immunoregulator
US8680059B2 (en) * 1998-05-20 2014-03-25 Biotempt B.V. Oligopeptide acetate and formulations thereof
US20030220258A1 (en) 2001-12-21 2003-11-27 Robbert Benner Treatment of ischemic events
WO2000023615A2 (fr) * 1998-10-15 2000-04-27 Bioimage A/S Procede ameliore destine a une extraction quantitative d'information se rapportant a une influence sur une reponse cellulaire
CA2346937A1 (fr) * 1998-10-15 2000-04-27 Per O. G. Arkhammar Interventions therapeutiques specifiques obtenues par interference avec redistribution et ou ciblage
GB9901072D0 (en) * 1999-01-19 1999-03-10 Imp Cancer Res Tech Methods for detecting changes to a macromolecular component of a cell
AU3605600A (en) * 1999-02-26 2000-09-14 Cellomics, Inc. A system for cell-based screening
DE19915310A1 (de) * 1999-04-03 2000-10-05 Bayer Ag Diffusionskontrollierende Sensorschicht
EP1048952B1 (fr) * 1999-04-29 2003-03-26 Erasmus Universiteit Rotterdam Détermination de la mobilité d'un analyte
US6743576B1 (en) 1999-05-14 2004-06-01 Cytokinetics, Inc. Database system for predictive cellular bioinformatics
US20030228565A1 (en) * 2000-04-26 2003-12-11 Cytokinetics, Inc. Method and apparatus for predictive cellular bioinformatics
US7151847B2 (en) 2001-02-20 2006-12-19 Cytokinetics, Inc. Image analysis of the golgi complex
US6651008B1 (en) 1999-05-14 2003-11-18 Cytokinetics, Inc. Database system including computer code for predictive cellular bioinformatics
WO2000070528A2 (fr) * 1999-05-14 2000-11-23 Cytokinetics, Inc. Procede et appareil de bioinformatique cellulaire previsionnelle
EP1055929A1 (fr) * 1999-05-26 2000-11-29 Tibotec N.V. Moyens et procédé pour la découverte des médicaments et la caractérisation des cellules
US6573059B1 (en) * 1999-06-04 2003-06-03 Rmf Dictagene S.A. Use of the regulatory subunit of the camp dependent protein kinase (PKA) from dictyostelium for camp measurements
AU5870800A (en) * 1999-06-09 2000-12-28 Ljl Biosystems, Inc. Cell-signaling assays
US6673554B1 (en) 1999-06-14 2004-01-06 Trellie Bioinformatics, Inc. Protein localization assays for toxicity and antidotes thereto
WO2000079241A2 (fr) * 1999-06-21 2000-12-28 Cellomics, Inc. Systeme d'examen systematique de cellules
US6121047A (en) * 1999-07-21 2000-09-19 Isis Pharmaceuticals Inc. Antisense modulation of SHP-1 expression
US6489151B1 (en) * 2000-03-27 2002-12-03 The Research Foundation Of State University Of New York Biologically active alternative form of the IKKα IκB kinase
EP1300418A1 (fr) * 2001-10-04 2003-04-09 Erasmus Universiteit Rotterdam Régulation génétique par des oligopeptides
KR100414641B1 (ko) 2000-04-07 2004-01-13 동부한농화학 주식회사 형질전환식물체의 생체분석방법 및 그를 이용한 시스템
WO2001079526A2 (fr) * 2000-04-17 2001-10-25 Bioimage A/S Procede faisant appel a des cellules vivantes pour identifier des composes modulant la distribution intracellulaire de phosphodiesterases (pde)
US20030162165A1 (en) * 2000-04-26 2003-08-28 Arkhammer Per O.G. Chemical signal enhancement of dynamic intensity-based intracellular protein-and fluorophore-based redistribution assays for drug-screening
AU2001270126A1 (en) * 2000-06-23 2002-01-08 Cytokinetics, Inc. Image analysis for phenotyping sets of mutant cells
CA2414626A1 (fr) * 2000-07-04 2002-01-10 Bioimage A/S Technique permettant d'extraire des informations quantitatives relatives aux interactions entre des composants cellulaires
US7625951B2 (en) 2000-07-13 2009-12-01 University Of Kentucky Research Foundation Stimuli-responsive hydrogel microdomes integrated with genetically engineered proteins for high-throughput screening of pharmaceuticals
DE10037759A1 (de) * 2000-08-03 2002-07-04 Gruenenthal Gmbh Screeningverfahren
KR100414781B1 (ko) * 2000-11-24 2004-01-13 재단법인서울대학교산학협력재단 ＮＦ-κＢ 발현을 인간 피부세포에서 정량적으로 측정하기위한 안정한 분석시스템 및 그의 용도
US7218764B2 (en) 2000-12-04 2007-05-15 Cytokinetics, Inc. Ploidy classification method
US6956961B2 (en) 2001-02-20 2005-10-18 Cytokinetics, Inc. Extracting shape information contained in cell images
US7016787B2 (en) 2001-02-20 2006-03-21 Cytokinetics, Inc. Characterizing biological stimuli by response curves
US7033790B2 (en) 2001-04-03 2006-04-25 Curagen Corporation Proteins and nucleic acids encoding same
JP2005507650A (ja) 2001-08-01 2005-03-24 セロミックス インコーポレイテッド 新規融合タンパク質及び分子結合に関するアッセイ
AU2002358657A1 (en) * 2001-12-10 2003-06-23 Evotec Oai Ag Method for determining the influence of non-physiological compounds the derivatives and decomposition products thereof on organisms organs and cells
US7176303B2 (en) * 2003-11-06 2007-02-13 Isis Pharmaceuticals, Inc. Modulation of STAT5 expression
US7560433B2 (en) 2001-12-21 2009-07-14 Biotempt B.V. Treatment of multiple sclerosis (MS)
US7786084B2 (en) * 2001-12-21 2010-08-31 Biotempt B.V. Treatment of burns
US20080318871A1 (en) * 2001-12-21 2008-12-25 Khan Nisar A Treatment of neurological disorders
US20080242837A1 (en) * 2001-12-21 2008-10-02 Khan Nisar A Peptide compositions
US20030220257A1 (en) * 2001-12-21 2003-11-27 Robbert Benner Treatment of trauma
US7329502B2 (en) 2002-04-25 2008-02-12 The United States Of America As Represented By The Department Of Health And Human Services ZAP-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
GB0216674D0 (en) * 2002-07-18 2002-08-28 Amersham Biosciences Uk Ltd Functional screening method
US8168568B1 (en) 2003-03-10 2012-05-01 The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Combinatorial therapy for protein signaling diseases
US20050014217A1 (en) 2003-07-18 2005-01-20 Cytokinetics, Inc. Predicting hepatotoxicity using cell based assays
EP1646926A2 (fr) 2003-07-18 2006-04-19 Cytokinetics, Inc. Caracterisation de stimuli biologiques par courbes de reponse
US7235353B2 (en) 2003-07-18 2007-06-26 Cytokinetics, Inc. Predicting hepatotoxicity using cell based assays
US20050060100A1 (en) * 2003-09-15 2005-03-17 Becton Dickinson And Company Computer software and algorithms for systems biologically linked to cellular phenotype
US20050059083A1 (en) * 2003-09-15 2005-03-17 Becton Dickinson And Company High throughput method to identify ligands for cell attachment
US20090227505A1 (en) * 2004-01-07 2009-09-10 Biotempt B.V. Methods and uses for protein breakdown products
US8586294B2 (en) 2004-05-18 2013-11-19 The Board Of Trustees Of The Leland Stanford Junior University Detection of protein translocation by beta-galactosidase reporter fragment complementation
US7323318B2 (en) 2004-07-15 2008-01-29 Cytokinetics, Inc. Assay for distinguishing live and dead cells
US8084260B2 (en) * 2004-11-24 2011-12-27 Applied Biosystems, Llc Spectral calibration method and system for multiple instruments
WO2007004869A2 (fr) * 2005-07-05 2007-01-11 Biotempt B.V. Traitement de tumeurs
JP2009513150A (ja) * 2005-10-28 2009-04-02 ジーイー・ヘルスケア・ユーケイ・リミテッド シグナリングアッセイ及び株化細胞
US20090170091A1 (en) * 2006-01-17 2009-07-02 Kenneth Giuliano Method For Predicting Biological Systems Responses
EP1864692A1 (fr) * 2006-06-07 2007-12-12 Biotempt B.V. Utilisation de peptides pour la protection contre les radiolésions
US8114615B2 (en) 2006-05-17 2012-02-14 Cernostics, Inc. Method for automated tissue analysis
US20100112602A1 (en) * 2006-11-10 2010-05-06 Taylor Lansing D Protein-Protein Interaction Biosensors and Methods of Use Thereof
WO2008085963A1 (fr) * 2007-01-05 2008-07-17 University Of Florida Research Foundation, Inc. Matériaux et procédés pour la détection, la prévention et le traitement d'une maladie auto-immune
PL2120991T3 (pl) * 2007-02-12 2014-07-31 Biotempt Bv Leczenie urazów krwotocznych krótkimi oligopeptydami
US20080217002A1 (en) * 2007-03-07 2008-09-11 Floyd Randolph Simonds Sand control screen having a micro-perforated filtration layer
JP5438962B2 (ja) * 2008-12-25 2014-03-12 シスメックス株式会社 細胞画像表示装置
US8574837B2 (en) 2008-12-29 2013-11-05 President And Fellows Of Harvard College System for screening agonists/antagonists of cellular signaling pathways
KR101088605B1 (ko) 2009-06-30 2011-11-30 한국산업기술대학교산학협력단 2대의 카메라를 이용한 세포 조작 방법
JP5089713B2 (ja) * 2010-01-18 2012-12-05 シャープ株式会社 画像圧縮装置、圧縮画像出力装置、画像圧縮方法、コンピュータプログラム及び記録媒体
AU2012229102B2 (en) 2011-03-17 2016-02-04 Cernostics, Inc. Systems and compositions for diagnosing Barrett's esophagus and methods of using the same
WO2013138684A1 (fr) 2012-03-15 2013-09-19 Montana Molecular Llc Capteurs fluorescents génétiquement codés pour détecter la signalisation intracellulaire par l'intermédiaire de voies du diacylglycérol
EP2682187B1 (fr) * 2012-07-02 2017-09-13 Molecular Devices, LLC Méthode de sélection et appareil
CA2929392A1 (fr) 2013-11-04 2015-05-07 Montana Molecular Llc Detecteurs fluorescents codant genetiquement pour la detection de ligandes biaises et signalisation intracelluaire par des voies de camp
DE102014012130B3 (de) 2014-08-13 2015-03-05 Alfred-Wegener-Institut, Helmholtz-Zentrum für Polar- und Meeresforschung Nachweisverfahren unter Verwendung von rekombinanten lebenden Zellen zum Nachweis von xenobiotischen Stoffen sowie Anordnung und Testkit zur Durchführung des Nachweisverfahrens

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT321257B (de) 1971-05-26 1975-03-25 Koreska Gmbh W Anlage zur Rückgewinnung flüchtiger Lösungsmittel
JPS57198544A (en) * 1981-05-28 1982-12-06 Sony Corp Manufacture of magnetic recording medium
JPS5880136A (ja) * 1981-11-02 1983-05-14 Fuji Photo Film Co Ltd 磁気記録材料の製造方法
DE3240063A1 (de) 1981-11-02 1983-05-26 Basf Ag, 6700 Ludwigshafen Vorrichtung zur herstellung eines magnetogrammtraegers
JPH0656656B2 (ja) * 1983-10-03 1994-07-27 富士写真フイルム株式会社 磁気記録媒体の製造方法
JPS6292132A (ja) * 1985-10-18 1987-04-27 Fuji Photo Film Co Ltd 磁気記録媒体の製造方法
US4923766A (en) * 1988-03-29 1990-05-08 Canon Kabushiki Kaisha Process for preparing magnetic recording
GB8916806D0 (en) * 1989-07-22 1989-09-06 Univ Wales Medicine Modified proteins
DE4009797A1 (de) * 1990-03-27 1991-10-02 Pagendarm Gmbh Verfahren und anordnung zum kondensieren von dampffoermigen substanzen
AU677834B2 (en) * 1993-04-07 1997-05-08 Cancer Research Ventures Limited Methods for screening of substances for therapeutic activityand yeast for use therein
ATE400651T1 (de) * 1993-09-10 2008-07-15 Univ Columbia Verwendung von grünem fluoreszenzprotein
US6184205B1 (en) * 1994-07-22 2001-02-06 University Of North Carolina At Chapel Hill GRB2 SH3 binding peptides and methods of isolating and using same
WO1996003649A1 (fr) * 1994-07-22 1996-02-08 The University Of North Carolina At Chapel Hill PEPTIDES SE FIXANT AUX SH3 DE Src ET LEURS METHODES D'ISOLEMENT ET D'UTILISATION
US5874231A (en) * 1994-08-22 1999-02-23 Mcgill University Methods of screening for non-hormone compounds which effect modulation of polypeptide translation
US5958713A (en) 1995-01-31 1999-09-28 Novo Nordisk A/S Method of detecting biologically active substances by using green fluorescent protein
DE69618350T2 (de) * 1995-01-31 2002-09-19 Bioimage As Soeborg Ein verfahren zum nachweis biologisch aktiver substanzen
DK0851874T3 (da) * 1995-09-22 2000-03-06 Bioimage A S Hidtil ukendte varianter af grønt fluorescerende protein, GFP
CA2239951A1 (fr) * 1995-12-08 1997-06-12 The Government Of The United States, Represented By The Secretary, Depar Tment Of Health And Human Services Procedes et composition de surveillance de molecules de liaison a l'adn dans des cellules vivantes
US5874304A (en) * 1996-01-18 1999-02-23 University Of Florida Research Foundation, Inc. Humanized green fluorescent protein genes and methods
US5989835A (en) * 1997-02-27 1999-11-23 Cellomics, Inc. System for cell-based screening
WO1998002571A1 (fr) * 1996-07-16 1998-01-22 The Regents Of The University Of California Dosages de proteines kinases faisant appel a des substrats proteiques fluorescents
WO1998030715A1 (fr) * 1997-01-07 1998-07-16 California Institute Of Technology Detecteur optique de signalisation cellulaire
US6416959B1 (en) * 1997-02-27 2002-07-09 Kenneth Giuliano System for cell-based screening
ATE268008T1 (de) * 1997-02-27 2004-06-15 Cellomics Inc Ein system zur zellbasierten reihenuntersuchung
DE69804446T3 (de) * 1997-04-07 2006-08-24 Bioimage A/S Verfahren um quantitativen informationen über einflüsse auf zelluläre reaktionen zu entnehmen
WO2000049183A1 (fr) * 1999-02-17 2000-08-24 Clontech Laboratories, Inc. Detection de la camp dans des cellules vivantes par transfert d'energie de resonance de la fluorescence a l'aide de variants de la proteine gfp
US6573059B1 (en) * 1999-06-04 2003-06-03 Rmf Dictagene S.A. Use of the regulatory subunit of the camp dependent protein kinase (PKA) from dictyostelium for camp measurements

Also Published As

Publication number Publication date
EP1199564A3 (fr) 2002-05-08
DE69837118D1 (de) 2007-03-29
EP1435519A1 (fr) 2004-07-07
DE1199564T1 (de) 2003-11-27
DK1435519T3 (da) 2007-06-11
ES2191575T1 (es) 2003-09-16
ATE269975T1 (de) 2004-07-15
EP1199564B1 (fr) 2004-06-23
EP1435519B1 (fr) 2007-02-14
US20030082564A1 (en) 2003-05-01
JP2001522454A (ja) 2001-11-13
DE69804446D1 (de) 2002-05-02
AU6820998A (en) 1998-10-30
ATE215227T1 (de) 2002-04-15
DK0986753T3 (da) 2002-07-22
PT1199564E (pt) 2004-10-29
DE69804446T2 (de) 2002-11-07
US8058008B2 (en) 2011-11-15
PT986753E (pt) 2002-09-30
EP0986753A2 (fr) 2000-03-22
EP0986753B2 (fr) 2005-08-10
US6518021B1 (en) 2003-02-11
ATE354089T1 (de) 2007-03-15
WO1998045704A3 (fr) 1999-04-22
CA2286293C (fr) 2004-04-06
ES2173573T5 (es) 2006-03-01
EP1199564A2 (fr) 2002-04-24
CA2286293A1 (fr) 1998-10-15
DE69824763D1 (de) 2004-07-29
DE69837118T2 (de) 2007-12-27
ES2191575T3 (es) 2005-02-01
DE69804446T3 (de) 2006-08-24
DE69824763T2 (de) 2005-07-07
WO1998045704A2 (fr) 1998-10-15
EP0986753B1 (fr) 2002-03-27
ES2173573T3 (es) 2002-10-16
US20090023598A1 (en) 2009-01-22

Similar Documents

Publication Publication Date Title
DK0986753T3 (da) Fremgangsmåde til uddragning af kvantitativ information, hvad angår en påvirkning af et cellulært respons
Gong et al. High-speed recording of neural spikes in awake mice and flies with a fluorescent voltage sensor
Betzig et al. Imaging intracellular fluorescent proteins at nanometer resolution
Lotze et al. Depletion, degradation, and recovery potential of estuaries and coastal seas
Li et al. Response to Comment on “Extended-resolution structured illumination imaging of endocytic and cytoskeletal dynamics”
Chen et al. Characterization of spectral FRET imaging microscopy for monitoring nuclear protein interactions
Bernhard et al. Use of the fluorescent calcite marker calcein to label foraminiferal tests
He et al. Quantitative and comparative profiling of protease substrates through a genetically encoded multifunctional photocrosslinker
DE69700902T2 (de) Verfahren zur erkennung von ligandenpaar bindung mit erhöter empfindlichkeit
Volschenk A new technique for examining surface morphosculpture of scorpions
Ebbert et al. Up‐regulation of a photosystem II core protein phosphatase inhibitor and sustained D1 phosphorylation in zeaxanthin‐retaining, photoinhibited needles of overwintering Douglas fir
Francis et al. Bioluminescence spectra from three deep-sea polychaete worms
Ruhlandt et al. Absolute quantum yield measurements of fluorescent proteins using a plasmonic nanocavity
Tuson et al. Addressing the Requirements of High‐Sensitivity Single‐Molecule Imaging of Low‐Copy‐Number Proteins in Bacteria
Celano et al. Seafinding revisited: how hatchling marine turtles respond to natural lighting at a nesting beach
Coulson et al. On the Collembola, Araneae and Gamasida from the Kinnvika region of Nordaustlandet, Svalbard
Wallrabe et al. IQGAP1 interactome analysis by in vitro reconstitution and live cell 3‐color FRET microscopy
JP2005283322A (ja) 撮影装置
Chen et al. Bioinspired, vertically stacked, and perovskite nanocrystal–enhanced CMOS imaging sensors for resolving UV spectral signatures
Plyushcheva et al. Two-color fluorescence in elytra of the scale-worm Lepidonotus squamatus (Polychaeta, Polynoidae): In vivo spectral characteristic
Zhu et al. Single-cell proteomics reveals downregulation of TMSB4X to drive actin release for stereocilia assembly
Kato et al. Practical guide of live imaging for developmental biologists
Pélissier-Monier et al. Performing chromophore-assisted laser inactivation in drosophila embryos using GFP
Yano et al. Analyses of the bioluminescence mechanism in the land snail, Quantula weinkauffiana
Kerr et al. Sinistral Coiling in the Arboreal Snail Partula gibba Férussac, 1821 (Stylommatophora: Partulidae) from Guam, Mariana Islands